Innovaro Pharmalicensing

Innovaro Pharmalicensing is a premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Innovaro Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.

Innovaro Pharmalicensing, and its sister service Innovaro Medical Device Licensing are actively utilized by over 200,000 industry professionals each month. Innovaro Pharmalicensing is part of Innovaro Inc, listed on AMEX (INV).

Innovaro Pharmalicensing
View Sample
from this Publisher


Adobe Acrobat
required
 

List of reports from Innovaro Pharmalicensing

< prev 1  2  next >
Strategies for Biogeneric Success
5/1/2004 | published by: Innovaro Pharmalicensing
... consistently to GMP and demonstrate its essential similarity to originator products? Having made the product, can you get it to market? Having accessed the market, are you able to make a profit from the sales ...  |  more...
$1,800.00
Intellectual Property Strategies for Pharmaceutical Development
5/1/2004 | published by: Innovaro Pharmalicensing
... actions. The report also deals with the different types of inventions that may occur. According to Tufts University in 2003, a new chemical entity (NCE) costs on average US$897 million to develop, including cost of ...  |  more...
$1,200.00
Late Stage Deals: Strategy, Structure and Payment Terms
8/1/2004 | published by: Innovaro Pharmalicensing
... to complex discovery and target research and development deals. Dealmaking has existed since the beginnings of the industry, since the advent of proprietary medications, patents and latter emergence of biotechnology entrepreneurs. The extent of dealmaking ...  |  more...
$1,800.00
Partneringdesk deals and alliances in oncology
6/1/2005 | published by: Innovaro Pharmalicensing
... activity • benchmarking deals • comparing the finances of different deal types. Partneringdesk deals and alliances in oncology brings all the relevant partnering deals into one place, providing a ready reference to deal making in ...  |  more...
$2,495.00
Reissuing pharmaceuticals in the NHS: Challenging the Chain of Trust
10/1/2005 | published by: Innovaro Pharmalicensing
... care. This report examines and questions the introduced DoH policy to show how it may represent a significant challenge to the integrity of the Chain of Trust, which offers protection to both manufacturers and patients. ...  |  more...
$1,200.00
Partneringdesk Deals and Alliances In Cardiovascular Diseases
1/1/2006 | published by: Innovaro Pharmalicensing
... (USPs and key questions answered) Partneringdesk Deals and alliances in cardiovascular diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...  |  more...
$2,495.00
Partneringreview 2006 - Full Report
2/1/2006 | published by: Innovaro Pharmalicensing
... the finances of different deal types compare? Want to know what the early, clinical and late stage developments are? Interested in new merger and acquisition activity over 2005? Curious about financing investments from lead investors? ...  |  more...
$3,995.00
Partneringreview 2006 - Company Deal Index (Volume 1)
2/1/2006 | published by: Innovaro Pharmalicensing
... A clear and easy way to see the activities of any company. Every deal by every company listed alphabetically. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, ...  |  more...
$2,495.00
Partneringreview 2006 - Therapy Area (Volume 2)
2/1/2006 | published by: Innovaro Pharmalicensing
... deal announcements in therapeutic areas - oncology, infectious disease, cardiovascular, circulatory, central nervous system, autoimmune, inflammation, metabolism, respiratory, gastrointestinal, musculoskeletal, sensory organ, oral health, genitourinary, gynecology, dermatology, blood system, lymphatic system, and accident/hospital/trauma. Each sector ...  |  more...
$2,495.00
Partneringreview 2006 - Financings (Volume 3)
2/1/2006 | published by: Innovaro Pharmalicensing
... way to see the investment activities of any company. Every deal by every company listed alphabetically. Every financing - grant/award deal is fully categorized, includes a detailed description, and includes financials such as headline value, ...  |  more...
$2,495.00
Partneringreview 2006 - Stage of Development (Volume 4)
2/1/2006 | published by: Innovaro Pharmalicensing
... 2,600 deal announcements from discovery stage deals to marketed - the full list of stages covered - discovery, lead molecule, preclinical, phase I, phase I/II, phase II, phase II/III, pre-registration, regulatory approval, marketing and formulation ...  |  more...
$2,495.00
Partneringreview 2006 - Deal Type (Volume 5)
2/1/2006 | published by: Innovaro Pharmalicensing
... announcements by deal type including licensing, cross license, technology access, sublicense, evaluation, letter of intent, co-marketing, co-promotion, contract marketing, contract manufacture, marketing, promotion, OEM, purchase, supply, distribution, manufacturing, collaborative R&D, CRADA, co-development, contract development, contract ...  |  more...
$2,495.00
Partneringreview 2006 - Industry Sector (Volume 6)
2/1/2006 | published by: Innovaro Pharmalicensing
... deal announcements in nine industry sectors - pharmaceutical, biotechnology, discovery, research tools, diagnostic, medical device, bioinformatics, drug delivery, and academic/government. Each sector is further divided to analyze deals by company, therapy area and stage of ...  |  more...
$2,495.00
Legal Aspects Of Outsourcing Contracts In The Pharmaceutical Industry: A Practical Guide
2/1/2006 | published by: Innovaro Pharmalicensing
... exploitation, including preclinical and clinical research, manufacture, logistics and sales. By affording a background to the key legal issues in this field, this provides a manual for individuals new to outsourcing, as well as support ...  |  more...
$895.00
Business Opportunities in China: The Impact of the WTO - 2nd Edition
3/1/2006 | published by: Innovaro Pharmalicensing
... competitiveness of the Chinese pharmaceutical industry in the international market The R&D and business opportunities for pharmaceutical firms considering alliances in China Significant points for consideration for companies looking to capture business opportunities in China.  |  more...
$795.00
India: Pharmaceutical and Biotechnology Opportunities
4/1/2006 | published by: Innovaro Pharmalicensing
... overview of the Indian pharma and biotech market, and answers the following key questions: Who are the key players in the Indian pharmaceutical market? How has the Indian regulatory environment changed? What R&D collaborative opportunities ...  |  more...
$1,200.00
Partneringdesk Deals and Alliances In Oncology
6/1/2006 | published by: Innovaro Pharmalicensing
... purchase (USPs and key questions answered): Partneringdesk Deals and alliances in oncology provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Central Nervous System Diseases
6/1/2006 | published by: Innovaro Pharmalicensing
... format. Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in central nervous system diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Metabolic Diseases
6/1/2006 | published by: Innovaro Pharmalicensing
... (USPs and key questions answered) Partneringdesk Deals and alliances in metabolic diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Musculoskeletal Diseases
6/1/2006 | published by: Innovaro Pharmalicensing
... and key questions answered) Partneringdesk Deals and alliances in musculoskeletal diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Genitourinary And Gynecological Diseases
6/1/2006 | published by: Innovaro Pharmalicensing
... format. Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in genitourinary and gynecological diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Dermatological Diseases
6/1/2006 | published by: Innovaro Pharmalicensing
... (USPs and key questions answered) Partneringdesk Deals and alliances in dermatological diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Blood And Lymphatic Diseases
6/1/2006 | published by: Innovaro Pharmalicensing
... format. Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in blood and lymphatic diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Respiratory Diseases
6/1/2006 | published by: Innovaro Pharmalicensing
... and key questions answered) Partneringdesk Deals and alliances in respiratory diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment ...  |  more...
$2,495.00
Partneringdesk Deals and Alliances In Hospital, Accident and Trauma
6/1/2006 | published by: Innovaro Pharmalicensing
... format. The report contains: fully categorized deal overviews financial information where disclosed company profiles of the top 25 dealmakers in the report specialized indexes by company, development stage, deal type and industry sector. wider coverage ...  |  more...
$2,495.00
< prev 1  2  next >